Publications by authors named "Giovanni Condemi"

Claim this Profile
I
Italian Survey on adjuvant treatment of non-small cell lung cancer (ISA).
Giuseppe Luigi Banna, Massimo Di Maio, Alessandro Follador, Elena Collovà, Jessica Menis, Giovanni Condemi

Lung Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Pasquale Comella, Bruno Massidda, Donato Natale, Carlo Putzu, Claudia Sandomenico, Giovanni Condemi

Clin Colorectal Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal carcinomatosis of colorectal origin.
Antonio Macrì, Edoardo Saladino, Vincenzo Bartolo, Vincenzo Adamo, Giuseppe Altavilla, Giovanni Condemi

World J Gastrointest Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, Antonio Farris, Donato Natale, Giovanni Condemi

J Cancer Res Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferences of patients with advanced colorectal cancer for treatment with oral or intravenous chemotherapy.
Candida M Mastroianni, Caterina Viscomi, Silvia Ceniti, Rosanna De Simone, Aldo Filice, Giovanni Condemi

Patient· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-patient alternated dose escalation of paclitaxel and gemcitabine versus paclitaxel followed by fixed dose rate infusion of gemcitabine in fit elderly non-small cell lung cancer patients. A Southern Italy Cooperative Oncology Group randomised phase II trial.
Pasquale Comella, Carlo Putzu, Bruno Massidda, Giovanni Condemi, Giuseppe De Cataldis

Lung Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis